Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by intellectual deficit associated with facial dysmorphism, patella luxation, and abnormal growth of the teeth.
Features include: Epicanthus, Abnormality of the dentition, Strabismus, and Inguinal hernia and 21 more.
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Prieto syndrome
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Strabismus, Nystagmus, Ptosis |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Brain shrinkage (cerebral atrophy) |
Brain and nerves | 2 | Intellectual disability, Brain shrinkage (cerebral atrophy) |
Bones and joints | 1 | Weak and brittle bones (osteoporosis) |
Arms and legs | 1 | Radial deviation of finger |
Skin | 1 | Skin dimple |
WNK3 function has not been fully characterized.
Prieto syndrome is associated with mutations in the WNK3 gene on chromosome X.
Genetic testing for WNK3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Prieto syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Prieto syndrome.
158 publications have been identified in PubMed for Prieto syndrome. Research spans Review / Meta-Analysis (54%), Basic Science / Preclinical (20%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 86 | 54% |
Laboratory research | 32 | 20% |
Patient case studies | 18 | 11% |
Disease patterns and progression | 10 | 6% |
Other research | 4 | 3% |
Testing and diagnosis research | 4 | 3% |
New treatment approaches | 3 | 2% |
Clinical study results | 1 | 1% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Bruschi F (2026). [PMID: 41144879](https://pubmed.ncbi.nlm.nih.gov/41144879/). *Mov Disord*. [Basic Science / Preclinical]
Boelaert K (2026). [PMID: 41508830](https://pubmed.ncbi.nlm.nih.gov/41508830/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Laaraje A (2026). [PMID: 40980854](https://pubmed.ncbi.nlm.nih.gov/40980854/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Li W (2026). [PMID: 42147817](https://pubmed.ncbi.nlm.nih.gov/42147817/). *Hum Mutat*. [Basic Science / Preclinical]
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Soodhana D (2025). [PMID: 40416472](https://pubmed.ncbi.nlm.nih.gov/40416472/). *J ASEAN Fed Endocr Soc*. [Case Report / Case Series]
Munarriz PM (2025). [PMID: 40214267](https://pubmed.ncbi.nlm.nih.gov/40214267/). *Neurosurgery*. [Basic Science / Preclinical]